General Announcement::iX Biopharma Reports Success of Single-Dose Wafermine Clinical Trials

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Sep-2015 17:09:58
Status
New
Announcement Sub Title
iX Biopharma Reports Success of Single-Dose Wafermine Clinical Trials
Announcement Reference
SG150917OTHRNVKZ
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

Press Release - iX Biopharma Reports Success of Single-Dose Wafermine Clinical Trials.pdf
Total size =52K